The Heart Attack Diagnostics Market is segmented according to diagnostic type, application area, technology, end user, and region.

By diagnostic type, the market includes electrocardiogram (ECG), blood tests, imaging tests, and echocardiography. Blood tests represented the largest segment in 2025 with a 43.5% share, while ECG technologies are evolving rapidly through integration with artificial intelligence.

By application area, the market supports diagnosis of acute myocardial infarction, cardiovascular disease risk assessment, and prognosis and monitoring of heart failure.

Based on technology, the industry includes traditional diagnostics, wearable ECG devices, AI-powered diagnostics, and implantable monitoring systems. AI-enabled and wearable technologies are expected to experience strong growth as healthcare providers increasingly adopt remote and connected diagnostic solutions.

By end user, hospitals and clinics represent the largest category, followed by diagnostic laboratories, home healthcare settings, and emergency medical services. Hospitals accounted for 51.1% of global revenue in 2025.

Regionally, the market covers North America, Europe, Asia-Pacific, South America, and the Middle East & Africa. North America currently leads the market, while Asia-Pacific is forecast to achieve the highest regional growth rate.